Treatment of chronic hepatitis C in naive patients with high-dose interferon-α2a induction therapy and two different ribavirin doses

被引：3
|
作者：
Hass, HG [1 ]
Nehls, O
Gregor, M
Kaiser, S
Kreysel, C
机构：
[1] Univ Tubingen, Dept Gastroenterol Hepatol & Infect Dis, Tubingen, Germany
[2] Klinikum Krefeld, Dept Gastroenterol, Krefeld, Germany
来源：
DIGESTIVE AND LIVER DISEASE | 2004年 / 36卷 / 05期
关键词：
D O I：
10.1016/j.dld.2004.01.009
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [21] Effect of combination therapy with ribavirin and high-dose interferon-α2b for 24 weeks in chronic hepatitis C
    Abe, S
    Narita, R
    Oto, T
    Tabaru, A
    Otsuki, M
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 308 - 312
  • [22] Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
    Uyama, Hirokazu
    Nakamura, Hideji
    Hayashi, Eijiro
    Ogawa, Hiroyuki
    Enomoto, Hirayuki
    Yoshida, Kenya
    Okuda, Yorihide
    Yamamoto, Mitsunari
    Hada, Toshikazu
    Hayashi, Norio
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (05) : 325 - 330
  • [23] IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C
    Lalezari, Jacob
    Box, Terry
    O'Riordan, William
    Mehra, Purvi
    Tuan Nguyen
    Poordad, Fred
    DeJesus, Edwin
    Kwo, Paul
    Godofsky, Eliot
    Lawrence, Shannon
    Dubuc-Patrick, Gloria
    Chen, Jie
    McCarville, Joseph
    Pietropaolo, Keith
    Zhou, Xiao-Jian
    Sullivan-Bolyai, John
    Mayers, Douglas
    [J]. ANTIVIRAL THERAPY, 2013, 18 (06) : 755 - 764
  • [24] Ribavirin treatment, but not interferon pharmacokinetics, is associated with suppression of viral rebounds during high dose interferon-α-2a therapy of hepatitis C infection
    Frost, S. D. W.
    Ruffini, L.
    Richman, D. D.
    Lake-Bakaar, G.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (05) : S13 - S13
  • [25] High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    [J]. HEPATOLOGY, 2001, 34 (04) : 581A - 581A
  • [26] Effect of interferon-λ4 on treatment response to peg-interferon-α-2a and ribavirin in patients with chronic hepatitis C
    Staettermayer, Albert
    Hofer, Harald
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Steindl-Munda, Petra E.
    Ferenci, Peter
    [J]. HEPATOLOGY, 2013, 58 : 1124A - 1125A
  • [27] Comparative study of the efficacy of an induction dose of interferon-α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C
    Pérez, R
    Jimènez, M
    Crespo, J
    Diago, M
    Enríquez, J
    Vaquero, P
    Solá, R
    Olcoz, JL
    Romero, M
    Salmerón, J
    Blanco, MI
    Oña, M
    Melón, S
    Rodrigo, L
    [J]. JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 437 - 445
  • [28] Clinical comparison of high-dose interferon-α2b with or without ribavirin for treatment of interferon-relapsed chronic hepatitis C
    Cheng, PN
    Chow, NH
    Hu, SC
    Young, KC
    Chen, CY
    Jen, CM
    Chang, TT
    [J]. DIGESTIVE AND LIVER DISEASE, 2002, 34 (12) : 851 - 856
  • [29] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
    Bergamini, A
    Bolacchi, F
    Cepparulo, M
    Demin, F
    Uccella, I
    Bongiovanni, B
    Ombres, D
    Angelico, F
    Liuti, A
    Hurtova, M
    Francioso, S
    Carvelli, C
    Cerasari, G
    Angelico, M
    Rocchi, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03): : 459 - 464
  • [30] Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy
    Kim, TH
    Kim, KA
    Lim, YS
    Gwak, GY
    Yoon, JH
    Kang, GH
    Lee, HS
    [J]. INTERVIROLOGY, 2005, 48 (04) : 230 - 238
12345